These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26881744)

  • 1. Kinome Profiling of Regulatory T Cells: A Closer Look into a Complex Intracellular Network.
    Tuettenberg A; Hahn SA; Mazur J; Gerhold-Ay A; Scholma J; Marg I; Ulges A; Satoh K; Bopp T; Joore J; Jonuleit H
    PLoS One; 2016; 11(2):e0149193. PubMed ID: 26881744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First insight into the kinome of human regulatory T cells.
    König S; Probst-Kepper M; Reinl T; Jeron A; Huehn J; Schraven B; Jänsch L
    PLoS One; 2012; 7(7):e40896. PubMed ID: 22815858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effector T cells boost regulatory T cell expansion by IL-2, TNF, OX40, and plasmacytoid dendritic cells depending on the immune context.
    Baeyens A; Saadoun D; Billiard F; Rouers A; Grégoire S; Zaragoza B; Grinberg-Bleyer Y; Marodon G; Piaggio E; Salomon BL
    J Immunol; 2015 Feb; 194(3):999-1010. PubMed ID: 25548233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Tolerance-Promoting Function of Regulatory T Cells Is Optimized by CD28, but Strictly Dependent on Calcineurin.
    Marangoni F; Zhang R; Mani V; Thelen M; Ali Akbar NJ; Warner RD; Äijö T; Zappulli V; Martinez GJ; Turka LA; Mempel TR
    J Immunol; 2018 May; 200(10):3647-3661. PubMed ID: 29661826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometry-based methods for studying signaling in human CD4+CD25+FOXP3+ T regulatory cells.
    Crellin NK; Garcia RV; Levings MK
    J Immunol Methods; 2007 Jul; 324(1-2):92-104. PubMed ID: 17582431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta2-adrenergic receptor signaling in CD4+ Foxp3+ regulatory T cells enhances their suppressive function in a PKA-dependent manner.
    Guereschi MG; Araujo LP; Maricato JT; Takenaka MC; Nascimento VM; Vivanco BC; Reis VO; Keller AC; Brum PC; Basso AS
    Eur J Immunol; 2013 Apr; 43(4):1001-12. PubMed ID: 23436577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-568 inhibits the activation and function of CD4⁺ T cells and Treg cells by targeting NFAT5.
    Li W; Kong LB; Li JT; Guo ZY; Xue Q; Yang T; Meng YL; Jin BQ; Wen WH; Yang AG
    Int Immunol; 2014 May; 26(5):269-81. PubMed ID: 24355664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD28/CTLA-4/B7 costimulatory pathway blockade affects regulatory T-cell function in autoimmunity.
    Vogel I; Kasran A; Cremer J; Kim YJ; Boon L; Van Gool SW; Ceuppens JL
    Eur J Immunol; 2015 Jun; 45(6):1832-41. PubMed ID: 25727069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity.
    Luo CT; Liao W; Dadi S; Toure A; Li MO
    Nature; 2016 Jan; 529(7587):532-6. PubMed ID: 26789248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
    Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
    Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex Vivo Signaling Protein Mapping in T Lymphocytes in the Psoriatic Arthritis Joints.
    Fiocco U; Martini V; Accordi B; Caso F; Costa L; Oliviero F; Scanu A; Felicetti M; Frallonardo P; Facco M; Boso D; Molena B; Zambello R; Ramonda R; Cozzi F; Scarpa R; Basso G; Semenzato G; Dayer JM; Doria A; Punzi L
    J Rheumatol Suppl; 2015 Nov; 93():48-52. PubMed ID: 26523057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Vive la Résistance!'--the PI3K-Akt pathway can determine target sensitivity to regulatory T cell suppression.
    Wohlfert EA; Clark RB
    Trends Immunol; 2007 Apr; 28(4):154-60. PubMed ID: 17329168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-α suppresses cAMP to disarm human regulatory T cells.
    Bacher N; Raker V; Hofmann C; Graulich E; Schwenk M; Baumgrass R; Bopp T; Zechner U; Merten L; Becker C; Steinbrink K
    Cancer Res; 2013 Sep; 73(18):5647-56. PubMed ID: 23878189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic Analyses of Human Regulatory T Cells Reveal Adaptations in Signaling Pathways that Protect Cellular Identity.
    Cuadrado E; van den Biggelaar M; de Kivit S; Chen YY; Slot M; Doubal I; Meijer A; van Lier RAW; Borst J; Amsen D
    Immunity; 2018 May; 48(5):1046-1059.e6. PubMed ID: 29752063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressive activity and altered conventional phenotype markers/mediators of regulatory T cells in patients with self-limiting hepatitis E.
    Rathod SB; Das R; Thanapati S; Arankalle VA; Tripathy AS
    J Viral Hepat; 2014 Feb; 21(2):141-51. PubMed ID: 24383927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined OX40L and mTOR blockade controls effector T cell activation while preserving T
    Tkachev V; Furlan SN; Watkins B; Hunt DJ; Zheng HB; Panoskaltsis-Mortari A; Betz K; Brown M; Schell JB; Zeleski K; Yu A; Kirby I; Cooley S; Miller JS; Blazar BR; Casson D; Bland-Ward P; Kean LS
    Sci Transl Med; 2017 Sep; 9(408):. PubMed ID: 28931653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane-bound Dickkopf-1 in Foxp3
    Chae WJ; Park JH; Henegariu O; Yilmaz S; Hao L; Bothwell ALM
    Immunology; 2017 Oct; 152(2):265-275. PubMed ID: 28556921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chromatin-modifying enzyme Ezh2 is critical for the maintenance of regulatory T cell identity after activation.
    DuPage M; Chopra G; Quiros J; Rosenthal WL; Morar MM; Holohan D; Zhang R; Turka L; Marson A; Bluestone JA
    Immunity; 2015 Feb; 42(2):227-238. PubMed ID: 25680271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative dose-responses of recombinant human IL-2 and IL-7 on STAT5 phosphorylation in CD4+FOXP3- cells versus regulatory T cells: a whole blood perspective.
    Dupont G; Demaret J; Venet F; Malergue F; Malcus C; Poitevin-Later F; Morel J; Monneret G
    Cytokine; 2014 Sep; 69(1):146-9. PubMed ID: 24947990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.